Immunocore Holdings Plc (IMCR)
32.93
+0.25
(+0.76%)
USD |
NASDAQ |
Feb 23, 16:00
32.91
-0.02
(-0.06%)
After-Hours: 19:59
Immunocore Holdings Shareholders Equity (Quarterly) : 396.56M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Silence Therapeutics Plc | 74.06M |
| Adaptimmune Therapeutics Plc | -70.96M |
| Biodexa Pharmaceuticals Plc | -- |
| Oxford Biomedica Plc | -- |
| NuCana Plc | 34.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.102B |
| Total Liabilities (Quarterly) | 705.94M |
| Debt to Equity Ratio | 1.099 |
| Current Ratio | 6.004 |
| Net Debt Paydown Yield | 0.40% |